Susquehanna International Group, LLP Evogene Ltd. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.45 - $3.45 $12,495 - $17,595
-5,100 Reduced 33.77%
10,000 $26,000
Q2 2021

Aug 11, 2021
SELL
$3.3 - $5.02 $13,530 - $20,582
-4,100 Reduced 21.35%
15,100 $52,000
Q1 2021

May 17, 2021
BUY
$4.29 - $9.94 $82,368 - $190,848
19,200 New
19,200 $97,000

Others Institutions Holding EVGN

# of Institutions
26
Shares Held
3.9M
Call Options Held
400
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $94.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email